Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (6,486,759)	$ (3,911,647)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	316,605	240,907
Stock-based compensation	386,289	536,244
Accretion on short-term investments	(432,942)	(67,160)
Change in fair value of warrant liability		(1,136,677)
Change in assets and liabilities:
Accounts and other receivables	(1,187,681)	432,101
Inventory	255,340	(751,920)
Prepaid expenses, operating lease right-of-use assets, and other assets	(343,714)	(621,710)
Accounts payable	155,275	33,888
Deferred revenue	591,940	(26,723)
Accrued expenses, lease liabilities, and other current liabilities	(1,657,962)	(1,240,371)
Net cash used in operating activities	(8,403,609)	(6,513,068)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment	(289,489)	(178,453)
Acquisition of intangible asset	(4,932)	(655,574)
Disposal of assets		1,960
Purchase of short-term investments	(20,978,738)	(23,015,397)
Proceeds from maturity of short-term investments	15,902,353	7,746,155
Net cash used in investing activities	(5,370,806)	(16,101,309)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from at-the-market equity financing, net of issuance costs	9,166,427
Proceeds from public issuance of common stock, net of offering costs	8,749,467
Issuance costs for public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants		(1,025)
Net cash provided by (used in) financing activities	17,915,894	(1,025)
Net increase (decrease) in cash and cash equivalents	4,141,479	(22,615,402)
Cash and cash equivalents at beginning of period	990,023	23,617,733
Cash and cash equivalents at end of period	5,131,502	1,002,331
Supplemental disclosure:
Acquisition of property and equipment included in accounts payable and accrued expenses	$ 21,405	$ 17,441